{"nctId":"NCT00270998","briefTitle":"ATLAS: Ambulatory Treatments for Leakage Associated With Stress","startDateStruct":{"date":"2005-06"},"conditions":["Stress Urinary Incontinence","Urinary Incontinence"],"count":445,"armGroups":[{"label":"Intravaginal Pessary","type":"EXPERIMENTAL","interventionNames":["Device: Intravaginal Pessary"]},{"label":"Behavioral Therapy","type":"EXPERIMENTAL","interventionNames":["Behavioral: Behavioral Therapy"]},{"label":"Pessary combined with behavioral therapy","type":"EXPERIMENTAL","interventionNames":["Device: Pessary combined with behavioral therapy"]}],"interventions":[{"name":"Behavioral Therapy","otherNames":[]},{"name":"Intravaginal Pessary","otherNames":[]},{"name":"Pessary combined with behavioral therapy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Stress urinary incontinence or stress-predominant mixed urinary incontinence, with at least 2 episodes of stress incontinence on 7-day bladder diary and the number of stress incontinence episodes exceeding the number of urge incontinence episodes.\n* Urinary incontinence for at least three months.\n* Ambulatory adult women.\n* Stage 0-I-II pelvic organ prolapse.\n\nExclusion Criteria:\n\n* Continual urine leakage.\n* Pregnancy or planning pregnancy within 1 year.\n* Active urinary tract infection.\n* Urinary retention.\n* Currently on medication for incontinence.\n* Currently using a pessary.\n* Neurologic condition that affects bladder function.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"\"Much Better\" or \"Very Much Better\" on PGI-I at 3 Months","description":"PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from \"not at all\" to \"very much better.\" Participants were considered a success if they responded \"much better\" or \"very much better,\" or a failure if they responded otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null},{"groupId":"OG001","value":"72","spread":null},{"groupId":"OG002","value":"59","spread":null}]}]}]},{"type":"PRIMARY","title":"No Bothersome Stress Incontinence Symptoms at 3 Months","description":"Success if participants answer either \"no\" or \"yes\" with a bother component of \"not at all\" or \"somewhat\" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"71","spread":null},{"groupId":"OG002","value":"49","spread":null}]}]}]},{"type":"SECONDARY","title":"\"Much Better\" or \"Very Much Better\" on PGI-I at 12 Months","description":"PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from \"not at all\" to \"very much better.\" Participants were considered a success if they responded \"much better\" or \"very much better,\" or a failure if they responded otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49","spread":null},{"groupId":"OG001","value":"48","spread":null},{"groupId":"OG002","value":"47","spread":null}]}]}]},{"type":"SECONDARY","title":"No Bothersome Stress Incontinence Symptoms at 12 Months.","description":"Success if participants answer either \"no\" or \"yes\" with a bother component of \"not at all\" or \"somewhat\" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49","spread":null},{"groupId":"OG001","value":"59","spread":null},{"groupId":"OG002","value":"52","spread":null}]}]}]},{"type":"SECONDARY","title":"75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months","description":"Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null},{"groupId":"OG001","value":"68","spread":null},{"groupId":"OG002","value":"69","spread":null}]}]}]},{"type":"SECONDARY","title":"75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months","description":"Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52","spread":null},{"groupId":"OG001","value":"54","spread":null},{"groupId":"OG002","value":"51","spread":null}]}]}]},{"type":"SECONDARY","title":"Satisfaction With Treatment at 3 Months","description":"Success if participant reported being \"satisfied\" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"118","spread":null},{"groupId":"OG001","value":"110","spread":null},{"groupId":"OG002","value":"94","spread":null}]}]}]},{"type":"SECONDARY","title":"Satisfaction With Treatment at 12 Months","description":"Success if participant reported being \"satisfied\" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null},{"groupId":"OG001","value":"79","spread":null},{"groupId":"OG002","value":"75","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":149},"commonTop":[]}}}